Health & Biotech
Ellex goes on a rollercoaster after results show laser therapy can fight vision loss
Expert view: why it’s a critical time for investment in ASX small cap health stocks
Cynata data shows promise in efforts to battle life-threatening condition
Canada is ‘the tip of the iceberg’ for legal cannabis, says boss of the biggest pot stock
Rhinomed soars as it closes a deal to ‘nasally deliver’ cannabis to Americans
Good news for pot stocks as US okays its first legal weed import
Aged care stocks are recovering this morning after yesterday’s big falls
Imugene appoints scientific advisor to tackle gastrointestinal cancer
Have a Coke and a big, big smile: Coca-Cola ‘closely watching’ the cannabis space
Impression wants you to chew cannabis gum to treat restless leg syndrome
Check Up: here’s what’s happening with 140 ASX small cap health stocks
Bowel cancer is rising in Asia but Rhythm Bio may be able to help
Pnina Feldman wanted to rename Queensland Bauxite ‘Joint Ventures Ltd’ after it went into hemp
Why this ASX cannabis stock is actually turning a profit
Cronos is selling recreational pot called ‘Spinach’ so kids won’t be tempted
AuMake wants to put its customers to sleep with Herbsmart buy-in
Australia’s pot police are hiring staff to cope with a long queue of cannabis applications
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
